메뉴 건너뛰기




Volumn 227, Issue , 2016, Pages 71-81

Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration

Author keywords

Chitosan; Galectin 1; Glioblastoma; Intranasal; Nanoparticles; siRNA

Indexed keywords

CHITIN; CHITOSAN; NEUROPHYSIOLOGY; SUSPENSIONS (FLUIDS); TUMORS;

EID: 84962282234     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2016.02.032     Document Type: Article
Times cited : (135)

References (58)
  • 4
    • 84924536171 scopus 로고    scopus 로고
    • Convection-enhanced delivery for the treatment of glioblastoma
    • M.A. Vogelbaum, and M.K. Aghi Convection-enhanced delivery for the treatment of glioblastoma Neuro-Oncology 17 Suppl. 2 2015 ii3 ii8
    • (2015) Neuro-Oncology , vol.17 , pp. ii3-ii8
    • Vogelbaum, M.A.1    Aghi, M.K.2
  • 6
    • 33845218355 scopus 로고    scopus 로고
    • Dendritic cell vaccination in patients with malignant gliomas: Current status and future directions
    • (discussioin 999-1000)
    • S. de Vleeschouwer, M. Rapp, R.V. Sorg, H.J. Steiger, W. Stummer, S. van Gool, and M. Sabel Dendritic cell vaccination in patients with malignant gliomas: current status and future directions Neurosurgery 59 2006 988 999 (discussioin 999-1000)
    • (2006) Neurosurgery , vol.59 , pp. 988-999
    • De Vleeschouwer, S.1    Rapp, M.2    Sorg, R.V.3    Steiger, H.J.4    Stummer, W.5    Van Gool, S.6    Sabel, M.7
  • 10
    • 84870982871 scopus 로고    scopus 로고
    • Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination
    • S. De Vleeschouwer, H. Ardon, F. Van Calenbergh, R. Sciot, G. Wilms, J. van Loon, J. Goffin, and S. Van Gool Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination Cancer Immunol. Immunother. 61 2012 2105 2112
    • (2012) Cancer Immunol. Immunother. , vol.61 , pp. 2105-2112
    • De Vleeschouwer, S.1    Ardon, H.2    Van Calenbergh, F.3    Sciot, R.4    Wilms, G.5    Van Loon, J.6    Goffin, J.7    Van Gool, S.8
  • 12
    • 84874065710 scopus 로고    scopus 로고
    • Vaccine strategies for glioblastoma: Progress and future directions
    • C. Jackson, J. Ruzevick, H. Brem, and M. Lim Vaccine strategies for glioblastoma: progress and future directions Immunotherapy 5 2013 155 167
    • (2013) Immunotherapy , vol.5 , pp. 155-167
    • Jackson, C.1    Ruzevick, J.2    Brem, H.3    Lim, M.4
  • 13
    • 84937434464 scopus 로고    scopus 로고
    • Current challenges in designing GBM trials for immunotherapy
    • S.P. Weathers, and M.R. Gilbert Current challenges in designing GBM trials for immunotherapy J. Neuro-Oncol. 2015
    • (2015) J. Neuro-Oncol.
    • Weathers, S.P.1    Gilbert, M.R.2
  • 14
    • 69949148057 scopus 로고    scopus 로고
    • Immunotherapy of diffuse gliomas: Biological background, current status and future developments
    • O.M. Grauer, P. Wesseling, and G.J. Adema Immunotherapy of diffuse gliomas: biological background, current status and future developments Brain Pathol. 19 2009 674 693
    • (2009) Brain Pathol. , vol.19 , pp. 674-693
    • Grauer, O.M.1    Wesseling, P.2    Adema, G.J.3
  • 20
    • 33749556658 scopus 로고    scopus 로고
    • Galectin-1: A small protein with major functions
    • I. Camby, M. Le Mercier, F. Lefranc, and R. Kiss Galectin-1: a small protein with major functions Glycobiology 16 2006 137R 157R
    • (2006) Glycobiology , vol.16 , pp. 137R-157R
    • Camby, I.1    Le Mercier, M.2    Lefranc, F.3    Kiss, R.4
  • 24
    • 84888294933 scopus 로고    scopus 로고
    • Vascular galectins: Regulators of tumor progression and targets for cancer therapy
    • V.L. Thijssen, G.A. Rabinovich, and A.W. Griffioen Vascular galectins: regulators of tumor progression and targets for cancer therapy Cytokine Growth Factor Rev. 24 2013 547 558
    • (2013) Cytokine Growth Factor Rev. , vol.24 , pp. 547-558
    • Thijssen, V.L.1    Rabinovich, G.A.2    Griffioen, A.W.3
  • 30
    • 0034095651 scopus 로고    scopus 로고
    • Transport of drugs from the nasal cavity to the central nervous system
    • L. Illum Transport of drugs from the nasal cavity to the central nervous system Eur. J. Pharm. Sci. 11 2000 1 18
    • (2000) Eur. J. Pharm. Sci. , vol.11 , pp. 1-18
    • Illum, L.1
  • 31
    • 68649090916 scopus 로고    scopus 로고
    • Nanoparticles for direct nose-to-brain delivery of drugs
    • A. Mistry, S. Stolnik, and L. Illum Nanoparticles for direct nose-to-brain delivery of drugs Int. J. Pharm. 379 2009 146 157
    • (2009) Int. J. Pharm. , vol.379 , pp. 146-157
    • Mistry, A.1    Stolnik, S.2    Illum, L.3
  • 32
    • 84860193946 scopus 로고    scopus 로고
    • Intranasal delivery of biologics to the central nervous system
    • J.J. Lochhead, and R.G. Thorne Intranasal delivery of biologics to the central nervous system Adv. Drug Deliv. Rev. 64 2012 614 628
    • (2012) Adv. Drug Deliv. Rev. , vol.64 , pp. 614-628
    • Lochhead, J.J.1    Thorne, R.G.2
  • 36
    • 0242288486 scopus 로고    scopus 로고
    • Absorption enhancers for nasal drug delivery
    • S.S. Davis, and L. Illum Absorption enhancers for nasal drug delivery Clin. Pharmacokinet. 42 2003 1107 1128
    • (2003) Clin. Pharmacokinet. , vol.42 , pp. 1107-1128
    • Davis, S.S.1    Illum, L.2
  • 37
    • 0035901694 scopus 로고    scopus 로고
    • Clearance characteristics of chitosan based formulations in the sheep nasal cavity
    • R.J. Soane, M. Hinchcliffe, S.S. Davis, and L. Illum Clearance characteristics of chitosan based formulations in the sheep nasal cavity Int. J. Pharm. 217 2001 183 191
    • (2001) Int. J. Pharm. , vol.217 , pp. 183-191
    • Soane, R.J.1    Hinchcliffe, M.2    Davis, S.S.3    Illum, L.4
  • 38
    • 33749844509 scopus 로고    scopus 로고
    • Development and characterisation of chitosan nanoparticles for siRNA delivery
    • H. Katas, and H.O. Alpar Development and characterisation of chitosan nanoparticles for siRNA delivery J. Control. Release 115 2006 216 225
    • (2006) J. Control. Release , vol.115 , pp. 216-225
    • Katas, H.1    Alpar, H.O.2
  • 39
    • 84877965095 scopus 로고    scopus 로고
    • Depletion of regulatory T cells in a mouse experimental glioma model through anti-CD25 treatment results in the infiltration of non-immunosuppressive myeloid cells in the brain
    • W. Maes, T. Verschuere, A. Van Hoylandt, L. Boon, and S. Van Gool Depletion of regulatory T cells in a mouse experimental glioma model through anti-CD25 treatment results in the infiltration of non-immunosuppressive myeloid cells in the brain Clin. Dev. Immunol. 2013 2013 952469
    • (2013) Clin. Dev. Immunol. , vol.2013 , pp. 952469
    • Maes, W.1    Verschuere, T.2    Van Hoylandt, A.3    Boon, L.4    Van Gool, S.5
  • 41
    • 33845784758 scopus 로고    scopus 로고
    • Blood-brain barrier delivery
    • W.M. Pardridge Blood-brain barrier delivery Drug Discov. Today 12 2007 54 61
    • (2007) Drug Discov. Today , vol.12 , pp. 54-61
    • Pardridge, W.M.1
  • 46
    • 68949208465 scopus 로고    scopus 로고
    • Nanocarriers' entry into the cell: Relevance to drug delivery
    • H. Hillaireau, and P. Couvreur Nanocarriers' entry into the cell: relevance to drug delivery Cell. Mol. Life Sci. 66 2009 2873 2896
    • (2009) Cell. Mol. Life Sci. , vol.66 , pp. 2873-2896
    • Hillaireau, H.1    Couvreur, P.2
  • 47
    • 84929938848 scopus 로고    scopus 로고
    • Intranasal delivery of chitosan-siRNA nanoparticle formulation to the brain
    • M. Malhotra, C. Tomaro-Duchesneau, S. Saha, and S. Prakash Intranasal delivery of chitosan-siRNA nanoparticle formulation to the brain Methods Mol. Biol. 1141 2014 233 247
    • (2014) Methods Mol. Biol. , vol.1141 , pp. 233-247
    • Malhotra, M.1    Tomaro-Duchesneau, C.2    Saha, S.3    Prakash, S.4
  • 49
    • 84878145752 scopus 로고    scopus 로고
    • Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor
    • D.T. Wiley, P. Webster, A. Gale, and M.E. Davis Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor Proc. Natl. Acad. Sci. U. S. A. 110 2013 8662 8667
    • (2013) Proc. Natl. Acad. Sci. U. S. A. , vol.110 , pp. 8662-8667
    • Wiley, D.T.1    Webster, P.2    Gale, A.3    Davis, M.E.4
  • 50
    • 68749099644 scopus 로고    scopus 로고
    • The alpha-galactomannan Davanat binds galectin-1 at a site different from the conventional galectin carbohydrate binding domain
    • M.C. Miller, A. Klyosov, and K.H. Mayo The alpha-galactomannan Davanat binds galectin-1 at a site different from the conventional galectin carbohydrate binding domain Glycobiology 19 2009 1034 1045
    • (2009) Glycobiology , vol.19 , pp. 1034-1045
    • Miller, M.C.1    Klyosov, A.2    Mayo, K.H.3
  • 53
    • 84899714252 scopus 로고    scopus 로고
    • Breaking barriers. New insights into airway epithelial barrier function in health and disease
    • F. Rezaee, and S.N. Georas Breaking barriers. New insights into airway epithelial barrier function in health and disease Am. J. Respir. Cell Mol. Biol. 50 2014 857 869
    • (2014) Am. J. Respir. Cell Mol. Biol. , vol.50 , pp. 857-869
    • Rezaee, F.1    Georas, S.N.2
  • 54
    • 1642579659 scopus 로고    scopus 로고
    • Effect of chitosan on epithelial cell tight junctions
    • J. Smith, E. Wood, and M. Dornish Effect of chitosan on epithelial cell tight junctions Pharm. Res. 21 2004 43 49
    • (2004) Pharm. Res. , vol.21 , pp. 43-49
    • Smith, J.1    Wood, E.2    Dornish, M.3
  • 55
    • 84883756054 scopus 로고    scopus 로고
    • Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles
    • T. Kanazawa, F. Akiyama, S. Kakizaki, Y. Takashima, and Y. Seta Delivery of siRNA to the brain using a combination of nose-to-brain delivery and cell-penetrating peptide-modified nano-micelles Biomaterials 34 2013 9220 9226
    • (2013) Biomaterials , vol.34 , pp. 9220-9226
    • Kanazawa, T.1    Akiyama, F.2    Kakizaki, S.3    Takashima, Y.4    Seta, Y.5
  • 56
    • 84859000580 scopus 로고    scopus 로고
    • Intranasal delivery of siRNA to the olfactory bulbs of mice via the olfactory nerve pathway
    • D.B. Renner, W.H. Frey 2nd, and L.R. Hanson Intranasal delivery of siRNA to the olfactory bulbs of mice via the olfactory nerve pathway Neurosci. Lett. 513 2012 193 197
    • (2012) Neurosci. Lett. , vol.513 , pp. 193-197
    • Renner, D.B.1    Frey, W.H.2    Hanson, L.R.3
  • 58
    • 0038819415 scopus 로고    scopus 로고
    • Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme
    • H. Wolburg, K. Wolburg-Buchholz, J. Kraus, G. Rascher-Eggstein, S. Liebner, S. Hamm, F. Duffner, E.H. Grote, W. Risau, and B. Engelhardt Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme Acta Neuropathol. 105 2003 586 592
    • (2003) Acta Neuropathol. , vol.105 , pp. 586-592
    • Wolburg, H.1    Wolburg-Buchholz, K.2    Kraus, J.3    Rascher-Eggstein, G.4    Liebner, S.5    Hamm, S.6    Duffner, F.7    Grote, E.H.8    Risau, W.9    Engelhardt, B.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.